| Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans J Mateus, A Grifoni, A Tarke, J Sidney, SI Ramirez, JM Dan, ZC Burger, ... Science 370 (6512), 89-94, 2020 | 1147 | 2020 |
| Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals A Tarke, J Sidney, N Methot, ED Yu, Y Zhang, JM Dan, B Goodwin, ... Cell Reports Medicine 2 (7), 2021 | 704* | 2021 |
| SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron A Tarke, CH Coelho, Z Zhang, JM Dan, ED Yu, N Methot, NI Bloom, ... Cell 185 (5), 847-859. e11, 2022 | 650 | 2022 |
| Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases A Tarke, J Sidney, CK Kidd, JM Dan, SI Ramirez, ED Yu, J Mateus, ... Cell Reports Medicine 2 (2), 2021 | 480 | 2021 |
| Humoral and cellular immune memory to four COVID-19 vaccines Z Zhang, J Mateus, CH Coelho, JM Dan, CR Moderbacher, RI Gálvez, ... Cell 185 (14), 2434-2451. e17, 2022 | 349 | 2022 |
| Early and polyantigenic CD4 T cell responses correlate with mild disease in acute COVID-19 donors A Tarke, M Potesta, S Varchetta, D Fenoglio, M Iannetta, L Sarmati, ... International journal of molecular sciences 23 (13), 7155, 2022 | 34 | 2022 |
| Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans A Grifoni, Y Zhang, A Tarke, J Sidney, P Rubiro, M Reina-Campos, ... Cell host & microbe 30 (12), 1662-1670. e4, 2022 | 33 | 2022 |
| Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status ED Yu, E Wang, E Garrigan, B Goodwin, A Sutherland, A Tarke, J Chang, ... Cell host & microbe 30 (3), 388-399. e3, 2022 | 30 | 2022 |
| Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study H Cohn, N Bloom, GY Cai, JJ Clark, A Tarke, MC Bermúdez-González, ... The Lancet Infectious Diseases 23 (11), 1302-1312, 2023 | 23 | 2023 |
| Targets and cross-reactivity of human T cell recognition of common cold coronaviruses A Tarke, Y Zhang, N Methot, TM Narowski, E Phillips, S Mallal, A Frazier, ... Cell Reports Medicine 4 (6), 2023 | 13 | 2023 |
| Development of exhaustion and acquisition of regulatory function by infiltrating CD8+ CD28− T lymphocytes dictate clinical outcome in head and neck cancer D Fenoglio, L Belgioia, A Parodi, F Missale, A Bacigalupo, A Tarke, ... Cancers 13 (9), 2234, 2021 | 9 | 2021 |
| In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burden V Ferrari, A Tarke, H Fields, L Ferrari, T Conley, F Ferrari, ... Cytotherapy 23 (4), 320-328, 2021 | 9 | 2021 |
| Adoptive transfer of neoantigen-specific T-cell therapy is feasible in older patients with higher-risk myelodysplastic syndrome TN Tanaka, V Ferrari, A Tarke, H Fields, L Ferrari, F Ferrari, CL McCarthy, ... Cytotherapy 23 (3), 236-241, 2021 | 9 | 2021 |
| Bioinformatic and experimental analysis of T cell immune reactivity to SARS-CoV-2 and its variants A Tarke, A Grifoni, A Sette Frontiers in Bioinformatics 2, 2022 | 8 | 2022 |
| PopCover-2.0. Improved selection of peptide sets with optimal HLA and pathogen diversity coverage JB Nilsson, A Grifoni, A Tarke, A Sette, M Nielsen Frontiers in Immunology 12, 728936, 2021 | 7 | 2021 |
| Mpox vaccine and infection-driven human immune signatures H Cohn, N Bloom, G Cai, J Clark, A Tarke, MC Bermúdez-González, ... medRxiv, 2023.03. 07.23286701, 2023 | 3 | 2023 |
| Asymptomatic or symptomatic SARS-CoV-2 infection plus vaccination confers increased adaptive immunity to variants of concern P Sun, I Ramos, CH Coelho, A Grifoni, CA Balinsky, S Vangeti, A Tarke, ... Iscience 25 (10), 2022 | 3 | 2022 |
| Tumor-specific T cell-mediated upregulation of PD-L1 in myelodysplastic syndrome cells does not affect T-cell killing V Ferrari, A Tarke, H Fields, TN Tanaka, S Searles, M Zanetti Frontiers in Oncology 12, 915629, 2022 | 2 | 2022 |
| Phenotypic and Proliferative Analysis of T Cell and Monocyte Populations in Patients with Intermediate/High/Very High-Risk MDS Compared to Age-Matched Healthy Donors H Fields, V Ferrari, A Tarke, RGS Tsai, T Luger, C McCarthy, R Chen, ... Blood 136, 25-26, 2020 | 1 | 2020 |
| T cell activation by OKT3 is a function of the percent monocytes in PBMC of healthy donors and MDS patients A Tarke, V Ferrari, H Fields, L Ferrari, F Ferrari, TN Tanaka, R Bejar, ... Blood 134, 4870, 2019 | 1 | 2019 |
